Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

10 results
Display

Medical Treatment of Pediatric Low-Grade Glioma

Lim YJ

Low-grade glioma (LGG) is the most common brain tumor in children and has excellent long-term survival. With an excellent survival rate, the choice of treatment involves careful consideration of minimizing...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Engineered Aurotherapy for the Multimodal Treatment of Glioblastoma

Kim HS, Lee DY

Glioblastoma multiforme (GBM) is the most aggressive brain tumor, characterized by fatal prognosis and high rates of recurrence. Although there are various treatment strategies such as surgical resection, radiotherapy, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Meningioma With Partial and Spontaneous Regression of Peritumoral Edema on Long-Term Follow Up

Kim Bs, Jung TY, Moon KS, Kim IY, Jung S

Spontaneous regression of meningioma is rarely observed. We report a one person of an incidentally diagnosed meningioma with a spontaneous regression. The 73-year-old female patient without symptoms showed the right...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Meningioma Originating From Choroid Plexus of Foramen of Luschka: A Rare Case Report and Tip of Differential Diagnosis

Lee YJ, Kim BS, Kim YJ, Lee KH, Jung S

Meningiomas are the most common benign brain tumors, and most of them originate from the dura mater. However, in some cases, they can originate from the choroid plexus, and they...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Spheno-Orbital Plasmacytoma as an Initial Presentation of Multiple Myeloma

Ahn S, Cha SH, Cho WH

Intracranial plasmacytoma is a rare neoplasm and a subtype of malignant plasma cell tumor. Most patients with plasma cell tumors are diagnosed with multiple myeloma, but 5%–10% of patients are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Proteomics of Extracellular Vesicle in Glioblastoma

Lee YJ, Seo CW, Lee D, Choi D

Glioblastoma multiforme (GBM), a high-grade astrocytic brain tumor, has highly aggressive and heterogeneous phenotypes with active cellular invasion, angiogenesis, and immune system modulation in the tumor microenvironment driven by complex...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Features and Prognosis of Diffuse Midline Glioma: A Series of 24 Cases

Jang SW, Song SW, Kim YH, Cho YH, Hong SH, Kim JH, Ra YS, Chong S

Background Diffuse midline glioma (DMG) which occurs in midline structures and characterized by harboring K27M mutation in genes encoding the histone 3 protein is classified as World Health Organization (WHO)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Anaplastic Meningioma: Clinical Characteristics, Prognostic Factors and Survival Outcome

Seo DO, Song SW, Kim YH, Hong CK, Kim JH

Background Anaplastic meningioma is very rare and is generally known to have a poor prognosis. However, due to its rarity, the relationship between clinical prognosis and prognostic factors is not clear....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Surgical Outcomes of Endoscopic Endonasal Versus Transcranial Resections of Adult Craniopharyngioma: A Meta-Analysis

Rafaqat W, Bajwa MH, Angez M, Enam SA

Background The endoscopic endonasal approach (EEA) has been gaining popularity for resection of adult craniopharyngiomas. However, the safety and effectiveness of the procedure in comparison to the traditional transcranial approach...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lumboperitoneal Shunt Combined With Ommaya Reservoir Enables Continued Intraventricular Chemotherapy for Leptomeningeal Metastasis With Increased Intracranial Pressure

Woo B, Gwak HS, Kwon JW, Shin SH, Yoo H

Background Intra-cerebrospinal fluid (CSF) chemotherapy for leptomeningeal metastasis (LM) can be delivered intraventricularly via an Ommaya reservoir. However, hydrocephalus associated with LM can interfere with chemotherapeutic drug distribution, and ventriculoperitoneal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr